Related Experiment Video
Updated: Jun 23, 2026

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
Published on: March 10, 2015
Efficacy of phthalocyanine tetrasulfonate against mouse-adapted human prion strains
Hanin Abdel-Haq1, Mei Lu, Franco Cardone
1Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy. hanin.abdelhaq@iss.it
Abstract:
In vitro and in vivo studies have shown that phthalocyanine tetrasulfonate (PcTS), a cyclic tetrapyrrole compound, is an efficient antiscrapie drug. To investigate the spectrum of PcTS against prion diseases, we tested the effect of PcTS on two mouse-adapted human strains. We also tested PcTS in rodents infected with two scrapie strains (139A and 263K). PcTS treatment significantly prolonged mean survival times of all infected animals. These results show that PcTS is effective on different prion strains, confirming its potential use for prion therapy.

